Carola A Huber (Carola Huber)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Atrial Fibrillation

Clinical Practice

Top Venues

Pharmacoepidemiology and drug safety

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tamino Zappalà, Jesper Hallas, Carola A Huber, Daphne Reinau, Christoph R Meier, Julia Spoendlin
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Pharmacoepidemiology and drug safety 33 (9) (2024)
Helena Aebersold, Fabienne Foster-Witassek, Miquel Serra-Burriel, Beat Brüngger, Stefanie Aeschbacher, Jürg-Hans Beer, Eva Blozik, Manuel Blum, Leo Bonati, David Conen, Giulio Conte, Stefan Felder, Carola A Huber, Michael Kuehne, Giorgio Moschovitis, Andreas Mueller, Rebecca E Paladini, Tobias Reichlin, Nicolas Rodondi, Anne Springer, Annina Stauber, Christian Sticherling, Thomas Szucs, Stefan Osswald, Matthias Schwenkglenks, null null
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls. BMJ open 13 (9) (2023)
Kevin Wirth, Caroline Bähler, Stefan Boes, Markus Näpflin, Carola A Huber, Eva Blozik
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting. BMJ open 13 (3) (2023)
Kevin Wirth, Caroline Bähler, Stefan Boes, Markus Näpflin, Carola A Huber, Eva Blozik
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting. BMJ open 13 (3) (2023)
Kevin Wirth, Stefan Boes, Markus Näpflin, Carola A Huber, Eva Blozik
Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting. BMJ open 13 (11) (2023)
Kevin Wirth, Caroline Bähler, Stefan Boes, Markus Näpflin, Carola A Huber, Eva Blozik
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting. BMJ open 13 (3) (2023)
Kevin Wirth, Caroline Bähler, Stefan Boes, Markus Näpflin, Carola A Huber, Eva Blozik
Opioid prescriptions after knee replacement: a retrospective study of pathways and prognostic factors in the Swiss healthcare setting. BMJ open 13 (3) (2023)
Nina L Wittwer, Christoph R Meier, Carola A Huber, Henriette E Meyer Zu Schwabedissen, Allemann Samuel, Cornelia Schneider
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database. Pharmacogenomics and personalized medicine 15 (2022)
Carola A Huber, Martin Scherer, Roland Rapold, Eva Blozik, null null
Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland. BMJ open 10 (4) (2020)
Carola A Huber, Reto Agosti, Markus Näpflin, Eva Blozik
Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database. Pharmacoepidemiology and drug safety 29 (3) (2019)